Syqe® Enquiry
SyqeAir® Metered Dose inhaler and SyqeAir® Cartridge
Please register your interest in the Syqe® product range below.
Syqe Publications, Clinical Trials and Medical Journal Information
Please find below access to a range of clinical trial and published journal articles regarding SyqeAir and treatments.
| Year | Authors / Publication Title / Journal | |
| 2023 | Joshua Aviram, Marek Glezerman, Eytan Hayam, Rostislav Belobrov, Shiri Procaccia, David Meiri and Elon Eisenberg Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler Pharmaceuticals 2023, 16(10), 1426 |
|
| 2022 | Joshua Aviram, Daniella Atzmony, Elon Eisenberg Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler PR9 7 (2022) e1011 |
|
| 2021 | Joshua Aviram, Dorit Pud, Tamar Gershoni, Bareket Schiff-Keren, Miriam Ogintz, Simon Vulfsons, Tamar Yashar, Haim-Moshe Adahan, Silviu Brill, Howard Amital, Itay Goor-Aryeh, Dror Robinson, Leslie Green, Refael Segal, Yacov Fogelman, Oren Tsvieli1, Ben Yellin, Yelena Vysotski, Ofir Morag, Vadim Tashlykov, Roee Sheinfeld, Ruth Goor, David Meiri and Elon Eisenberg Medical cannabis treatment for chronic pain: Outcomes and prediction of response DOI: 10.1002/ejp.1675 |
|
| 2020 | Simon Vulfsons, M.D, Miriam Ognitz, R.N, Gil Bar-Sela, M.D., Ayelet Raz-Pasteur, M.D. and Elon Eisenberg, M.D. Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study Palliative and Supportive Care 18, 12–17 |
|
| 2020 | Shlomo Almog, Judith Aharon-Peretz, Simon Vulfsons, Miri Ogintz, Hadas Abalia, Tal Lupo, Yael Hayon, Elon Eisenberg The pharmacokinetics, efficacy, and safety of a novel selectivedose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial Eur J Pain. 2020;24:1505–1516 |
|
| 2014 | Elon Eisenberg, Miri Ogintz, and Shlomo Almog The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered-Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study Journal of Pain & Palliative Care Pharmacotherapy. 2014;28:216–225 |
|